Australia - English - Department of Health (Therapeutic Goods Administration)

adnariam pty ltd - 63430 - steam inhaler - this hand-held steam inhaler is intended for the whole family, including children 13 years and over to alleviate the discomfort associated with upper respiratory conditions. it eases nasal congestion and sinus pressure by relieving inflammation. the steam acts as a mucolytic helping to thin sticky mucus allowing easy clearance of the airways.

United States - English - NLM (National Library of Medicine)

bluebay shandong co.,ltd - cysteamine hydrochloride (unii: if1b771svb) (cysteamine - unii:5ux2sd1ke2) -

Australia - English - Department of Health (Therapeutic Goods Administration)

3m australia pty ltd - 61871 - steam sterilization indication system - the primary function of the device is to monitor the air removal stage and the sterilization phase of a steam sterilization cycle.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - cysteamine bitartrate -

Israel - English - Ministry of Health

dexcel ltd, israel - iomeprol - solution for injection - iomeprol 816.5 mg/ml - watersoluble, nephrotropic, low osmolar x-ray contrast media - contrast medium for diagnostic radiography. intravenous urography (in adults ,including those with renal impairment or diabetes), ct (body), conventional angiography, intraarterial dsa, angiocardiography (in adults and pediatrics), conventional selective coronary arteriography, interventional coronary , arthrography, fistulography, galactography, dacryocystography, sialography.

United States - English - NLM (National Library of Medicine)

recordati rare diseases, inc. - cysteamine hydrochloride (unii: if1b771svb) (cysteamine - unii:5ux2sd1ke2) - cystadrops is a cystine-depleting agent indicated for the treatment of corneal cystine crystal deposits in adults and children with cystinosis. none. risk summary there are no adequate and well-controlled studies of ophthalmic cysteamine in pregnant women to inform any drug associated risks. oral administration of cysteamine to pregnant rats throughout the period of organogenesis was teratogenic at doses 240 to 960 times the recommended human ophthalmic dose (based on body surface area) [ see data] . cystadrops should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. data animal data teratology studies have been performed in rats at oral doses in the range of 37.5 mg/kg/day to 150 mg/kg/day (240 to 960 times the recommended human ophthalmic dose based on body surface area) and have shown cysteamine bitartrate to be teratogenic. observed teratogenic findings were intrauterine death, cleft palate, kyphosis, heart ventricular septal defects, microcephaly, exencephaly, and growth deficits. risk summary there is no information regarding the presence of cysteamine in human milk, the effects on the breastfed infants, or the effects on milk production. cysteamine administered orally is present in milk of lactating rats. it is not known whether measurable levels of cysteamine would be present in maternal milk following topical ocular administration of cystadrops. the developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for cystadrops and any potential adverse effects on the breastfed child from cystadrops or from the underlying maternal conditions. the safety and effectiveness of cystadrops has been established in pediatric patients. use of cystadrops is supported by adequate and well controlled trials in pediatric patients and additional experience supporting the safety of cystadrops. clinical studies of cystadrops did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. other reported clinical experience has not identified differences in responses between the elderly and younger patients.  the effect of renal impairment on the pharmacokinetics of cysteamine following ophthalmic administration of cysteamine ophthalmic solution has not been evaluated. clearance of cysteamine from the conjunctival sac of the eye is not dependent on renal function and the total systemic dose is negligible, so impaired renal function is unlikely to affect total body clearance. the total daily ophthalmic dose is less than 4% of the recommended oral daily dose of cysteamine; thus, the systemic exposure following ophthalmic administration is expected to be negligible compared to oral administration.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nutrien ag solutions limited - phosphoric acid - aqueous concentrate - phosphoric acid mineral-phosphorus-acid active 1200.0 g/l - dairy cleanser - dairy equipment stainless steel | dairy plant stainless steel | milking equipment | building | milking machine - milkstone removal | milk fat | milk protein | mineral deposits

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nutrien ag solutions limited - phosphoric acid; quaternary ammonium compound - aqueous concentrate - phosphoric acid mineral-phosphorus-acid active 500.0 g/l; quaternary ammonium compound ammonium-quaternary active 25.0 g/l - dairy cleanser - dairy equipment stainless steel | dairy plant stainless steel | milking equipment | building | milking machine - milkstone removal | milk fat | milk protein | mineral deposits

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

troy laboratories pty ltd - linolenic acid | linoleic acid | docosahexaenoic acid | eicosapentaenoic acid | zinc as zinc sulfate | vitamin e as dl-alpha tocopheryl acetate - nutrition & metabolism - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - allergic dermatitis | dermatoses - inflamation | fatty acid deficiency | atopy

Israel - English - Ministry of Health

dexcel ltd, israel - iomeprol - solution for injection - iomeprol 612.4 mg/ml - iomeprol - iomeprol - contrast medium for diagnostic radiology. intravenous urography ( in adults and paediatrics), peripheral phlebography, ct (brain and body), cavernosography, intravenous dsa, conventional angiography, intraarterial dsa, angiocardiography (in adults and paediatrics), conventional selective coronary arteriography, interventional coronary arteriography, ercp, arthrography, hysterosalpingography, fistulography, discography, galactography, chloangiography, dacryocystography, sialography, retrograde urethrography, retrograde pyelo-ureterography.